Benzamycin Kit
NDC Package 0187-5205-46
Package Information
Benzamycin (erythromycin and benzoyl peroxide) kits is a medication used to treat moderate acne. This formulation utilizes a kit delivery system. Marketed by Bausch Health Us, Llc, this product is identified by NDC 0187-5205 and is authorized under FDA application NDA050557.
Identification & Billing
- RxCUI: 213082 - Benzamycin 3 % / 5 % Topical Gel
- RxCUI: 213082 - benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]
- RxCUI: 213082 - Benzamycin (benzoyl peroxide 5 % / erythromycin 3 % ) Topical Gel
- RxCUI: 213082 - Benzamycin (benzoyl peroxide 50 MG / erythromycin 30 MG) per GM Topical Gel
- RxCUI: 244374 - erythromycin 3 % / benzoyl peroxide 5 % Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0187 - Bausch Health Us, Llc
- 0187-5205 - Benzamycin
- 0187-5205-46 - 1 KIT in 1 BOX * 1.6 g in 1 VIAL, PLASTIC * 40 g in 1 JAR
- 0187-5205 - Benzamycin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0187-5205-46 identifies a specific commercial package of 1 kit in 1 box * 1.6 g in 1 vial, plastic * 40 g in 1 jar of Benzamycin, a human prescription drug labeled by Bausch Health Us, Llc. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us, Llc on October 26, 1984. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to treat moderate acne. It helps to reduce the number of pimples. This medication is a combination of 2 drugs. Erythromycin works by stopping the growth of acne-causing bacteria. It belongs to a class of drugs known as macrolide antibiotics. Benzoyl peroxide also kills acne-causing bacteria and causes the top layer of skin to dry and peel off so that new skin can form. This product also contains alcohol which helps to dry extra oils from the skin.
How is this Bausch Health Us, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187520546. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.